A change in leadership at the Federal Trade Commission could spark mergers and acquisitions in tech, healthcare and beyond.

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Healthcare investors are desperate for big returns in a second Trump term. But his health policy proposals are making them ...

Several US health insurers saw notable stock price gains following the reelection of former US President Donald Trump amid an ...

CVS Pharmacy Inc. and the former president of Cigna Corp.'s Express Scripts asked a federal judge to amend an injunction ...

Biden antitrust enforcers sought to discourage all mergers. The new Trump Administration should revive a prior approach that ...

The tech industry is bracing for a vastly different relationship with the U.S. government as Donald Trump returns to the ...

Tod Northman and Ryan Kray of Tucker Ellis LLP discuss a final rule regarding premerger notification and report forms under ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

Trump has shown a reluctance to break up Google, despite ongoing cases brought up during Biden’s term. His comments have ...